Felgueres, M., Esteso, G., García-Jiménez, Á. F., Dopazo, A., Aguiló, N., Mestre-Durán, C., . . . Valés-Gómez, M. (2024). BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.
Citación estilo ChicagoFelgueres, María-José, et al. BCG Priming Followed By a Novel Interleukin Combination Activates Natural Killer Cells to Selectively Proliferate and Become Anti-tumour Long-lived Effectors. 2024.
Cita MLAFelgueres, María-José, et al. BCG Priming Followed By a Novel Interleukin Combination Activates Natural Killer Cells to Selectively Proliferate and Become Anti-tumour Long-lived Effectors. 2024.
Precaución: Estas citas no son 100% exactas.